My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Jubilant Life Sciences gains on USFDA nod for generic drug

Jubilant Life Sciences gains on USFDA nod for generic drug

Feb 27,2017

The announcement was made during market hours today, 27 February 2017.

Meanwhile, the S&P BSE Sensex was almost unchanged at 28,893.03.

On the BSE, 63,000 shares were traded on the counter so far as against the average daily volumes of 1.37 lakh shares in the past one quarter. The stock had hit a high of Rs 728 and a low of Rs 704 so far during the day.

The stock had hit a record high of Rs 765 on 7 February 2017 and a 52-week low of Rs 287.20 on 29 February 2016. It had underperformed the market over the past one month till 23 February 2017, gaining 4.7% compared with the Sensexs 6.55% rise. The scrip had also underperformed the market over the past one quarter, advancing 8.83% as against the Sensexs 10.91% rise.

The large-cap company has equity capital of Rs 15.93 crore. Face value per share is Rs 1.

ltraconazole Capsules, 100 mg, is the generic version of Sporanox of Janssen Pharmaceuticals, which is used for the treatment of fungal infections.

Jubilant Life Sciences has received 8 approvals from the United States Food and Drug Administration (USFDA) during the year. As on 31 December 2016, Jubilant Life Sciences had a total of 73 abbreviated new drug application (ANDAs) for oral solids filed in the US, of which 49 have been approved.

On a consolidated basis, Jubilant Life Sciences net profit fell 2.6% to Rs 119.78 crore on 8.7% growth in net sales to Rs 1438.81 crore in Q3 December 2016 over Q3 December 2015.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients and drug discovery solutions. The pharmaceuticals segment, through its wholly owned subsidiary Jubilant Pharma, is engaged in manufacture and supply of APIs, solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile and non-sterile products through 6 USFDA approved manufacturing facilities in India, USA and Canada.

The life science ingredients segment, is engaged in specialty intermediates, nutritional products and life science chemicals through 5 manufacturing facilities in India. The drug discovery solutions segment, provides proprietary in-house innovation & collaborative research and partnership for out-licensing through 3 world class research centres in India and USA.

Powered by Capital Market - Live News

TCS recognised among Achievers 50 Most Engaged Workplaces
Jun 28,2017

Tata Consultancy Services announced that it has been recognised as one of the Achievers 50 Most Engaged Workplaces in North America.

Powered by Capital Market - Live News

Sicagen India announces appointment of directors
Jun 28,2017

Sicagen India announced that the Board of the Company has appointed Rita Chandrasekar as an additional Director with immediate effect and she will act as Independent Director of the Company for a period of 5 years with effect from 28 June 2017. The Board has appointed Shridhar Gogte, as an additional Director with immediate effect and he will act as Whole Time Director of the Company for a period of 2 years with effect from 28 June 2017.

Powered by Capital Market - Live News

Jubilant Foodworks allots 31,920 equity shares
Jun 28,2017

Jubilant Foodworks has allotted 31,920 equity shares of face value of Rs. 10/- each to the employees of the Company on 28 June 2017 under ESOPs. Post allotment, the paid up capital has increased to 65,981,990 equity shares.

Powered by Capital Market - Live News

Board of Godrej Industries decides to participate in IPO of Godrej Agrovet
Jun 28,2017

The Board of Directors of Godrej Industries on 28 June 2017 has decided to participate in the Initial Public Offering of equity shares of its subsidiary, Godrej Agrovet. Godrej Industries proposes to sell such number of equity shares in Godrej Agrovet up to Rs 400 crore through the offer.

Powered by Capital Market - Live News

Hindusthan Urban Infrastructure announces resignation of CFO
Jun 28,2017

Hindusthan Urban Infrastructure announced that Anil Kumar Chandani, CFO and Key Managerial Personnel of the Company has resigned from the services of the Company. He will be relieved with effect from close of business hours of 04 August 2017.

Powered by Capital Market - Live News

Tayo Rolls deposits Rs 63.81 crore towards dues
Jun 28,2017

Tayo Rolls has deposited Rs 63,81,00,000 towards dues to the Banks.

Powered by Capital Market - Live News

Gajanan Securities Services approves change in registered office
Jun 28,2017

Gajanan Securities Services announced that the Board of Directors of the Company at its meeting held on 28 June 2017 has approved the change of Registered office of the company at the following address 113/1B, C.R.Avenue, 7th floor, Room No 7C, Kolkata-700073 w.e.f 01 June 2017

Powered by Capital Market - Live News

Edelweiss Financial Services allots 64,68,275 equity shares
Jun 28,2017

Edelweiss Financial Services has allotted 64,68,275 Equity Shares of the face value of Re. 1/- each under Edelweiss Employee Stock Option Scheme(s) of the Company.

Powered by Capital Market - Live News

Automobile Corporation Of Goa appoints director
Jun 28,2017

Automobile Corporation Of Goa announced the appointment of Abhay Bawale as Non-Executive Director on the Board of Directors of the Company effective 26 June 2017.

Powered by Capital Market - Live News

Zenith Birla (India) CEO resigns
Jun 28,2017

Zenith Birla (India) announced the resignation of Pushkar Natu from the post of CEO of the Company with effect from 28 June 2017.

Powered by Capital Market - Live News

Ashish Polyplast announces resignation of CFO
Jun 28,2017

Ashish Polyplast has received resignation letter from Rasikbhai Babaldas Panchal as on 28 June, 2017 for resigning from the post of Chief Financial Officer (CFO) with immediate effect from 28 June, 2017

Powered by Capital Market - Live News

Board of Aayush Food And Herbs approves change in directorate
Jun 28,2017

The Board of Directors of Aayush Food And Herbs at its meeting held on 28 June 2017 has approved the appointment of Pallavi Mittal as Managing Director of the Company with effect from 28 June 2017. The Board has also taken note of resignation of Sachin Goyal as CFO of the Company with effect from 16 June 2017.

Powered by Capital Market - Live News

Board of Country Condos approves change in directorate
Jun 28,2017

The Board of Directors of Country Condos at its meeting held on 28 June 2017 has approved the following -

The appointment of Mr. Kalidindi Subrahmanya Raju as an Additional Director (Independent Director).

Accepted the resignation of K. satyanarayana Raju as Director

Powered by Capital Market - Live News

Board of RCL Foods approves shifting of registered office
Jun 28,2017

The Board of Directors of RCL Foods in its meeting held on Wednesday the 28 June, 2017 has resolved to shift the registered office of the Company from No.200-A, Madhavaram High Road, Madhavaram, Chennai-600060 to Old No. 28, New No.16, Ranganathan Avenue, Kilpauk, Chennai-600010 with immediate effect.

Powered by Capital Market - Live News

Board of Mindtree approves buyback of shares
Jun 28,2017

The Board of Directors of Mindtree at its meeting held on 28 June 2017 has approved buyback of equity shares of the company not exceeding 43,20,000 equity shares, being 2.57% of the total paid up equity share capital at a price not exceeding Rs 625 per equity share for an aggregate amount of Rs 270 crore.

Powered by Capital Market - Live News